Shattuck Labs Inc
NASDAQ:STTK

Watchlist Manager
Shattuck Labs Inc Logo
Shattuck Labs Inc
NASDAQ:STTK
Watchlist
Price: 0.824 USD 1.85% Market Closed
Market Cap: 39.5m USD

Relative Value

The Relative Value of one STTK stock under the Base Case scenario is 0.676 USD. Compared to the current market price of 0.824 USD, Shattuck Labs Inc is Overvalued by 18%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

STTK Relative Value
Base Case
0.676 USD
Overvaluation 18%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
64
vs Industry
45
Median 3Y
43.6
Median 5Y
11.2
Industry
7.3
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-2.2
Industry
23.3
Forward
-0.8
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-2
Industry
19.8
vs History
vs Industry
Median 3Y
-1.2
Median 5Y
-1.8
Industry
22.6
vs History
89
vs Industry
68
Median 3Y
0.7
Median 5Y
0.8
Industry
2.7
vs History
vs Industry
22
Median 3Y
-2.4
Median 5Y
-2.5
Industry
7.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.4
vs History
38
vs Industry
24
Median 3Y
0.2
Median 5Y
0.2
Industry
4.7
Forward
0.3
vs History
25
vs Industry
23
Median 3Y
0.2
Median 5Y
-0
Industry
4.8
Forward
0.4
vs History
22
vs Industry
26
Median 3Y
0.2
Median 5Y
0
Industry
5.3
vs History
22
vs Industry
21
Median 3Y
0.2
Median 5Y
0
Industry
3.8
vs History
vs Industry
39
Median 3Y
-0.6
Median 5Y
0
Industry
5

Multiples Across Competitors

STTK Competitors Multiples
Shattuck Labs Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Shattuck Labs Inc
NASDAQ:STTK
39.5m USD 8.6 -0.6 0.3 0.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 841 650.5 -160 844.3 -195 316.3 -193 087.6
US
Abbvie Inc
NYSE:ABBV
344.4B USD 6 82.9 15.7 23.2
US
Amgen Inc
NASDAQ:AMGN
161.3B USD 4.7 27.2 14.6 24
US
Gilead Sciences Inc
NASDAQ:GILD
142.6B USD 5 23.9 10.4 14.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.5B USD 11.1 -124.8 26.6 27.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 081.7 -531.2 -578.4 -563
AU
CSL Ltd
ASX:CSL
117.4B AUD 5 27.9 17.2 21.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
60.6B USD 4.3 13.5 12 13.5
US
Seagen Inc
F:SGT
39.3B EUR 20.1 -61.5 -66.3 -59.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
42B USD 17.9 -155.8 -699.1 -350.3
P/E Multiple
Earnings Growth PEG
US
Shattuck Labs Inc
NASDAQ:STTK
Average P/E: 35.1
Negative Multiple: -0.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 844.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
82.9
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
27.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23.9
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -124.8 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.2 N/A N/A
AU
CSL Ltd
ASX:CSL
27.9
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.5
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.5 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -155.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Shattuck Labs Inc
NASDAQ:STTK
Average EV/EBITDA: 13.8
0.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 316.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.7
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.6
17%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.6
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -578.4 N/A N/A
AU
CSL Ltd
ASX:CSL
17.2
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -699.1 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Shattuck Labs Inc
NASDAQ:STTK
Average EV/EBIT: 17.8
0.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 087.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.2
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
24
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
14.3
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.9
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563 N/A N/A
AU
CSL Ltd
ASX:CSL
21.5
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.5
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.8 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -350.3 N/A N/A